CA 72-4
| Material: | 1 ml serum (stability in serum at 4°C – 8°C: > 14 days) |
| Methods: | Ligandenassays → Chemilumineszenz-Immunoassay (CLIA) | Reference range | < 6,9 U/ml |
| Indication | Therapy and progress checks of stomach carcinoma and mucinous ovarian carcinoma. |
| Please note | Simultaneous evaluation of CA 72-4 and CA 19-9 increases sensitivity. CA 72-4 increases are also seen in other tumors of the gastrointestinal tract, the lungs and breast and in other benign gastroenterological and gynaecological diseases. |
| External services | ja Labor Zentrum Weser Prof. Dr. med. Schmitz Minden |
| Accredited | ja |
More Results for the letter C
- Cryofibrinogen (KRYOFI)
- Cryoglobulins (KRYO)
- Cryptococcosis (CRYPA)
- Cryptococcus neoformans, Cryptococcus gattii
- Cryptosporidia (ECRYP, MCRYP)
- CSF diagnostics (bacteriological) (LIQUORB)
- CSF diagnostics (general) (LIQUOR)
- CXCL13 (CXCL13)
- Cyclosporine A (CYCLO)
- Ciclosporine
- Cyfra 21-1 (CYFRA)
- Cystatin C (CYSTA)
- Cysteine (CYSTC)
- Cysteinyl-Dopa (5SCY)
- 5-S-cysteinyl-Dopa
- Cystine (CYST)
- Cytomegalovirus infection (CMV)